Charles Schwab’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Charles Schwab’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-244	Closed	-$13K	–	3574
2022 Q2	$13K	Sell	244 -1,411	-85%	-$105K	﹤0.01%	3534
2022 Q1	$234K	Hold	1,655	–	–	﹤0.01%	3280
2021 Q4	$283K	Hold	1,655	–	–	﹤0.01%	3295
2021 Q3	$825K	Buy	1,655 +66	+4%	+$30.6K	﹤0.01%	2941
2021 Q2	$796K	Buy	1,589 +1,345	+551%	+$722K	﹤0.01%	3010
2021 Q1	$124K	Hold	244	–	–	﹤0.01%	3365
2020 Q4	$117K	Hold	244	–	–	﹤0.01%	3310
2020 Q3	$71K	Hold	244	–	–	﹤0.01%	3266
2020 Q2	$47K	Hold	244	–	–	﹤0.01%	3264
2020 Q1	$31K	Hold	244	–	–	﹤0.01%	3177
2019 Q4	$43K	Hold	244	–	–	﹤0.01%	3135
2019 Q3	$37K	Hold	244	–	–	﹤0.01%	3135
2019 Q2	$29K	Sell	244 -705	-74%	-$112K	﹤0.01%	3187
2019 Q1	$160K	Buy	949 +245	+35%	+$42K	﹤0.01%	3053
2018 Q4	$84K	Buy	704 +211	+43%	+$32.4K	﹤0.01%	3104
2018 Q3	$76K	Hold	493	–	–	﹤0.01%	3119
2018 Q2	$326K	Buy	+493	New	+$369K	﹤0.01%	2932
2017 Q2	–	Sell	-235	Closed	-$57K	–	3160
2017 Q1	$57K	Hold	235	–	–	﹤0.01%	3036
2016 Q4	$64K	Hold	235	–	–	﹤0.01%	3063
2016 Q3	$53K	Hold	235	–	–	﹤0.01%	3024
2016 Q2	$92K	Buy	+235	New	+$257K	﹤0.01%	3062
2015 Q2	–	Sell	-194	Closed	-$439K	–	3143
2015 Q1	$439K	Hold	194	–	–	﹤0.01%	2671
2014 Q4	$200K	Hold	194	–	–	﹤0.01%	2980
2014 Q3	$206K	Hold	194	–	–	﹤0.01%	2940
2014 Q2	$486K	Buy	194 +56	+41%	+$114K	﹤0.01%	2638
2014 Q1	$263K	Hold	138	–	–	﹤0.01%	2857
2013 Q4	$295K	Hold	138	–	–	﹤0.01%	2812
2013 Q3	$310K	Hold	138	–	–	﹤0.01%	2735
2013 Q2	$246K	Buy	+138	New	+$219K	﹤0.01%	2808

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Charles Schwab's AMPE Position: Q3 2022 in Review

Charles Schwab sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 244 shares — an estimated $13K sold.

Charles Schwab first reported a position in AMPE in Q2 2013 and held it in 29 quarters. The position peaked at $825K in Q3 2021. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

Charles Schwab reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
Charles Schwab sold 244 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $13K.
Charles Schwab first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 29 quarters.
Charles Schwab's Ampio Pharmaceuticals Inc. position peaked at $825K in Q3 2021.
95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.